Deidra Crews | |
---|---|
Academic background | |
Education | BSc, biology, 1995, University of Virginia MD, 2003, Saint Louis University School of Medicine ScM, clinical epidemiology, Johns Hopkins Bloomberg School of Public Health |
Academic work | |
Institutions | Johns Hopkins School of Medicine |
Deidra C. Crews MD,ScM is an American nephrologist and epidemiologist. She is the Deputy Director of Johns Hopkins Center for Health Equity and a Professor of Medicine at Johns Hopkins School of Medicine. Crews research focuses on social drivers of disparities in kidney disease and hypertension.
Crews completed her Bachelor of Arts degree in Biology from the University of Virginia before earning her medical degree at the Saint Louis University School of Medicine. [1] Upon graduating,she received the 2003 John H. Gladney,M.D. Diversity Award. [2] Following her MD,Crews completed her nephrology fellowship and a Master's degree in clinical epidemiology degree at Johns Hopkins School of Medicine. [1] As a senior postdoctoral fellow at Johns Hopkins,Crews was selected as a 2010-2014 Harold Amos Medical Faculty Development Program scholar,sponsored by the Robert Wood Johnson Foundation. [3] [4]
Following her fellowship,Crews joined the Division of Nephrology at the Johns Hopkins University School of Medicine as an instructor. Early in her career she used data from Healthy Aging in Neighborhoods of Diversity across the Lifespan Study to investigate why African Americans with incomes below the poverty line have a significantly higher risk of chronic kidney disease than their white counterparts. [5] She then collaborated with L. Ebony Boulware to develop interventions and strategies to improve dietary choices in the African-American population to help prevent chronic kidney disease. Their work was recognized with an inaugural President's Research Recognition Award in 2012. [6] As an assistant professor of nephrology,Crews continued to receive recognition for her work health,environmental,genetic,historical,cultural,and socioeconomic factors impacting African-American health,longevity,and quality of life. In April 2013,she was named the recipient of the second annual Ernest Just Prize. [7] She also received a K23 award from the National Institute of Diabetes and Digestive and Kidney Diseases for her project "Race,Socioeconomic Status,Diet and Chronic Kidney Disease" through 2017. [8] The following year,Crews was one of many Johns Hopkins faculty members honored with the 2014 Diversity Recognition Award. [9]
Outside of Johns Hopkins,Crews was appointed to the National Kidney Foundation of Maryland Board of Directors in June 2015. [10] She was also inducted into the Alpha Omega Alpha Honor Medical Society in 2017 [11] and appointed to the American Society of Nephrology's executive committee in 2018. [12] At the same time,Crews earned recognition from the National Academy of Medicine as an Emerging Leader in Health and Medicine Scholar for three years. [13] In further recognition of her work,Crews received Johns Hopkins President's Frontier Award as someone who is "poised to break new ground and be leaders in their fields." [12] The following year,she was also named one of the inaugural recipients of the American Society of Nephrology's Distinguished Leader Midcareer Award. [14]
During the COVID-19 pandemic,Crews co-authored articles examining how the novel coronavirus affects those with acute kidney injury. [15] She also sat on a task force that recommended Johns Hopkins Health System to discontinue a long-standing clinical standard that factors a patient's race into kidney function tests. [16] Crews' research was recognized at a national level with an election to the American Society for Clinical Investigation in 2020. [17] In January 2021,Crews stepped down as associate vice chair for diversity and inclusion. [18] She then led a successful application for the Mid-Atlantic Center for Cardiometabolic Health Equity alongside Lisa Cooper. The center's aim is to address cardiometabolic health disparities among socially disadvantaged populations across Maryland by testing the effectiveness of several evidence-based strategies. [19]
Crews was elected to the National Academy of Medicine in 2023. [20]
Antonia Coello Novello is a Puerto Rican physician and public health administrator. She was a vice admiral in the Public Health Service Commissioned Corps and served as 14th Surgeon General of the United States from 1990 to 1993. Novello was the first woman and first Hispanic to serve as Surgeon General. Novello also served as Commissioner of Health for the State of New York from 1999 to 2006. Novello has received numerous awards including more than fifty honorary degrees,was elected to the National Academy of Medicine in 2000,and has been inducted into the National Women's Hall of Fame.
Robert William Schrier was founding editor-in-chief of the magazine Nature Clinical Practice Nephrology. Schrier was formerly Chairman of the Department of Medicine at the University of Colorado School of Medicine for 26 years,and Head of the Division of Renal Diseases and Hypertension for 20 years. At the time of his death,he was Professor Emeritus at the University of Colorado School of Medicine. He died in Potomac,Maryland.
Bruce C. Kone is an American professor,nephrologist and molecular biologist. He is also a World Aquatics Masters Swimming world record holder,United States Masters Swimming (USMS) national record holder,twenty-three-time USMS national champion,and eight-time FINA Masters world's top-ranked age group swimmer. He is currently a tenured professor of medicine at the University of Texas Health Science Center at Houston (UTHealth).
Josephine P. Briggs is an American nephrologist and director emeritus of the National Center for Complementary and Integrative Health,an agency of the National Institutes of Health. She is currently the editor-in-chief of the Journal of the American Society of Nephrology.
Sharon A. Anderson is an American physician,educator,and researcher practicing in Portland,Oregon. She has contributed extensively to the study of the progression of chronic kidney disease. Her research has focused on diabetic nephropathy,polycystic kidney disease and the pathophysiology of the aging kidney. She was the first woman to serve as President of the American Society of Nephrology (ASN). She was the Chief of the Department of Medicine at the Veteran's Affairs Medical Center in Portland and is currently the Chair of the Department of Medicine at Oregon Health and Science University (OHSU). She has been appointed to the National Institutes of Health Council of Councils. Her publications as author or co-author number greater than 150.
Dorry L. Segev is the Marjory K. and Thomas Pozefsky Professor of Surgery at Johns Hopkins School of Medicine,professor of epidemiology at Johns Hopkins Bloomberg School of Public Health,and associate vice chair of the Department of Surgery at Johns Hopkins Hospital. He has made significant contributions to the field of transplantation,including developing a mathematical model to facilitate a nationwide kidney paired donation program,both in the US and Canada. He is also known for his role in getting the HIV Organ Policy Equity Act signed into law.
Jochen Reiser is a physician-scientist and a healthcare leader. He is the President of the University of Texas Medical Branch (UTMB) and CEO of the UTMB Health System,which includes the oldest Medical School and Nursing School in the state of Texas. As Chief Executive Officer,he oversees the enterprise which includes multiple campuses,five health science colleges,the Galveston National Laboratory (BSL-4) and the Correctional Health Care Services for most of Texas. Before UTMB,he served as the Ralph C Brown MD Professor and the Chairman of Medicine at Rush University Medical Center. Dr. Reiser's research has provided important mechanistic insights into the molecular pathogenesis of kidney diseases. Dr. Reiser discovered the role of suPAR as a global,circulating risk factor for chronic kidney disease (CKD) as well as for acute kidney injury (AKI). suPAR is investigated as potential causative agent contributing to many kidney diseases including focal segmental glomerulosclerosis (FSGS). These studies have broad clinical significance and lay the foundation for creation of novel diagnostics and pharmaco-therapeutics with potential benefit for a large patient population. His studies on suPAR molecule were featured in Science in 2018. Dr. Reiser has been an advocate of science and innovation for two decades and was named as an inventor on multiple patents. He is co-founder of Cambridge,MA-based Walden Biosciences,an ARCH Venture Partners joint-venture biopharmaceutical portfolio company dedicated to develop first-in-class therapeutics for kidney diseases.
Céline R. Gounder is an American physician and medical journalist who specializes in infectious diseases and global health. She was a member of the COVID-19 Advisory Board transition team of then-incoming U.S. president Joe Biden. In 2022,she joined the Kaiser Family Foundation as senior fellow and editor-at-large for public health at Kaiser Health News.
Neil R. Powe is an American professor of medicine at the University of California,San Francisco and the chief of medicine at the Zuckerberg San Francisco General Hospital and Trauma Center. Previously he was professor of medicine at the Johns Hopkins University School of Medicine. His research has mainly related to kidney disease,cardiovascular disease and health disparities.
Patricia Anne Acquaviva Gabow is an American academic physician,medical researcher,healthcare executive,author and lecturer. Specializing in nephrology,she joined the department of medicine,division of renal diseases,at the University of Colorado School of Medicine in 1973,advancing to a full professorship in 1987;she is presently Professor Emerita. She was the principal investigator on the National Institutes of Health Human Polycystic Kidney Disease research grant,which ran from 1985 to 1999,and defined the clinical manifestations and genetics of the disease in adults and children. She served for two decades as CEO of Denver Health,an integrated public healthcare system in Denver,Colorado,where she implemented numerous business-based systems to streamline operations,improve patient care,and recognize cost savings. In particular,her introduction of the "Lean" quality-improvement system,based on the Toyota Production System,earned her national recognition. She is the author of more than 150 articles and book chapters,three books,and has received numerous awards for excellence in teaching,physician care,and leadership. She was inducted into the Colorado Women's Hall of Fame in 2004.
Reshma Kewalramani,is the president and chief executive officer of Vertex Pharmaceuticals,a biotechnology company based in Boston,Massachusetts,as of April 1,2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.
Maria M. Oliva-Hemker is a Cuban-American pediatrician. She is the Stermer Family Professor of Pediatric Inflammatory Bowel Disease (IBD),Director of the Division of Pediatric Gastroenterology,Hepatology and Nutrition and Vice Dean for Faculty at the Johns Hopkins University School of Medicine.
Robert H. "Heppy" Heptinstall was an English pathologist specialising in renal pathology. He was the chair of the department of pathology at Johns Hopkins Hospital for 19 years.
Adeera Levin MD,FRCPC is a Professor of Medicine,and is head of the Division of Nephrology at University of British Columbia.
Josef Coresh is an American epidemiologist. He is the inaugural George W. Comstock Professor in the Department of Epidemiology at Johns Hopkins University. Coresh serves as the director of both the Cardiovascular Epidemiology Training Program and the George W. Comstock Center for Public Health Research and Prevention at the Johns Hopkins School of Medicine.
Samira Farouk,MD,MS,FASN is a board-certified transplant nephrologist and Associate Professor of Medicine and Medical Education at Icahn School of Medicine at Mount Sinai (ISMMS). She teaches medical students,residents,and fellows,and also develops and studies innovations in medical education. Her clinical research interests include the pathogenesis of kidney fibrosis in regards to transplant survival and chronic kidney diseases. Farouk is also cofounder of the free mobile-friendly nephrology teaching tool NephSIM,Associate Program Director of the Nephrology Fellowship at ISMMS,and Director of Mentoring and Trainee Engagement of KIDNEYcon.
Leigh Ebony Boulware is an American general internist,physician-scientist,and clinical epidemiologist. She is the Dean of Wake Forest School of Medicine and chief science officer and vice chief academic officer of Advocate Health. Boulware formerly served as the Nanaline Duke Distinguished Professor of Medicine and director of the Clinical and Translational Science Institute at the Duke University School of Medicine.
Rulan S. Parekh is an American-Canadian clinician-scientist and nephrologist. She is the vice president of research,education and innovation at Women's College Hospital and former senior scientist in Child Health Evaluative Sciences and Associate Chief of Clinical Research at SickKids.
Sherita Hill Golden is an American physician who is the Hugh P. McCormick Family Professor of Endocrinology and Metabolism at Johns Hopkins University. She also serves as vice president and chief diversity officer. Her research considers biological and systems influences on diabetes and its outcomes. She was elected Fellow of National Academy of Medicine in 2021.
Morgan Erika Grams is an American nephrologist. She is the Co-Director of the Division of Precision Medicine,and the Susan and Morris Mark Professor in the Departments of Medicine and Population Health at NYU Langone Health.
Deidra Crews publications indexed by Google Scholar